Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial

Ozlem Aslan1, Mattia Cremona2, Clare Morgan2

  • 1Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland. ozlemasl@gmail.com.

BMC Cancer
|February 11, 2018
PubMed
Abstract

Insights

Targeting the phosphoinositide-3-kinase (PI3K) and RAS/MAPK pathways shows promise in endometrial cancer (EC). MEK inhibition is effective for KRAS-mutated and PTEN-retained EC, with potential biomarkers identified.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The phosphoinositide-3-kinase (PI3K) pathway is frequently activated in cancers, including endometrial cancer (EC).
  • Mutations in PI3K and RAS/RAF/MEK/MAPK (RAS/MAPK) pathways often co-occur in EC.
  • PTEN loss is a common event contributing to PI3K pathway activation.

Purpose of the Study:

  • To investigate the role of PI3K and RAS/MAPK pathway mutations in EC.
  • To determine the responsiveness of EC cell lines to targeted therapies against PI3K and MEK pathways.
  • To identify potential biomarkers for predicting treatment response.

Main Methods:

  • Profiling of 13 EC cell lines for PI3K pathway, KRAS mutations, and PTEN protein status.
  • Treatment with MEK and PI3K inhibitors, alone and in combination.
  • Analysis of signaling pathway changes using Reverse-Phase-Protein-Array (RPPA).

Main Results:

  • PTEN loss and absence of mutations predicted poor response to MEK inhibition.
  • KRAS-mutated cells were sensitive to MEK inhibitors but resistant to PI3K inhibitors.
  • Combinations of PI3K and MEK inhibitors demonstrated synergy or additivity in most cell lines.
  • Feedback activation of MEK/MAPK and AKT pathways was observed in response to PI3K and MEK inhibition, respectively.

Conclusions:

  • MEK inhibition is a potential treatment for EC, particularly for tumors with mutated KRAS or retained PTEN.
  • Up-regulation of MEK/MAPK and AKT signaling may serve as predictive biomarkers for PI3K and MEK inhibitors, respectively.
  • Targeting these pathways offers a promising therapeutic strategy for endometrial cancer.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Phase Transitions: Sublimation and Deposition02:33

Phase Transitions: Sublimation and Deposition

Some solids can transition directly into the gaseous state, bypassing the liquid state, via a process known as sublimation. At room temperature and standard pressure, a piece of dry ice (solid CO2) sublimes, appearing to gradually disappear without ever forming any liquid. Snow and ice sublimate at temperatures below the melting point of water, a slow process that may be accelerated by winds and the reduced atmospheric pressures at high altitudes. When solid iodine is warmed, the solid sublimes...
20.4K
Phase Diagrams02:39

Phase Diagrams

A phase diagram combines plots of pressure versus temperature for the liquid-gas, solid-liquid, and solid-gas phase-transition equilibria of a substance. These diagrams indicate the physical states that exist under specific conditions of pressure and temperature and also provide the pressure dependence of the phase-transition temperatures (melting points, sublimation points, boiling points). Regions or areas labeled solid, liquid, and gas represent single phases, while lines or curves represent...
50.5K
Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.3K
Phase Transitions: Melting and Freezing02:39

Phase Transitions: Melting and Freezing

Heating a crystalline solid increases the average energy of its atoms, molecules, or ions, and the solid gets hotter. At some point, the added energy becomes large enough to partially overcome the forces holding the molecules or ions of the solid in their fixed positions, and the solid begins the process of transitioning to the liquid state or melting. At this point, the temperature of the solid stops rising, despite the continual input of heat, and it remains constant until all of the solid is...
15.3K